创新炎症负荷指数用于识别肺栓塞患者高死亡风险:一项大型回顾性队列研究
该研究回顾性分析1642例急性肺栓塞患者,中位随访41.2个月期间262例(16.0%)死亡。高炎症负荷指数(IBI)与全因死亡风险独立相关(校正HR 2.33,95%CI 1.78至3.04;p<0.001),且预测准确性优于C反应蛋白、中性粒细胞计数和淋巴细胞计数。
要点
- 高IBI与急性肺栓塞患者长期全因死亡风险独立相关(校正HR 2.33,95%CI 1.78至3.04;p<0.001)。
- IBI预测1、3、5年死亡的AUC分别为0.73、0.74、0.75,高于C反应蛋白、中性粒细胞计数和淋巴细胞计数。
- 将IBI加入基本临床模型可显著提高各时间点的AUC;随机生存森林分析确认IBI是最重要的炎症预测因子。
核心结论
- IBI是急性肺栓塞患者长期死亡的稳健且独立的预测因子,在传统危险因素之外提供增量预后价值。
- 将IBI纳入临床风险分层可能改善患者管理和结局。
研究设计与样本
- 回顾性分析1642例急性肺栓塞患者。
- 采用最大选择秩统计量确定IBI最佳截断值;使用多因素Cox比例风险模型评估高IBI与全因死亡的关系;采用时间依赖ROC曲线比较IBI及其各组成部分的预测性能;采用随机生存森林(RSF)分析评估变量重要性。
主要发现
- 中位随访41.2个月期间,262例患者(16.0%)死亡。
- 高IBI与全因死亡风险升高独立相关(校正HR 2.33,95%CI 1.78至3.04;p<0.001)。
- 时间依赖ROC分析显示IBI对死亡预测的AUC在1年、3年、5年分别为0.73、0.74、0.75,高于C反应蛋白、中性粒细胞计数和淋巴细胞计数。
- 将IBI加入基本临床模型后,各时间点AUC均显著提高。
- RSF分析确认IBI是长期死亡最重要的炎症预测因子。
关键数值与推荐
- IBI最佳截断值由最大选择秩统计量确定(原文未报告具体数值)。
- 高IBI与全因死亡的校正HR为2.33(95%CI 1.78至3.04;p<0.001)。
- IBI预测1年、3年、5年死亡的AUC分别为0.73、0.74、0.75。
临床怎么用
- 作者认为将IBI纳入临床风险分层可能改善患者管理和结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background The prognostic significance of systemic inflammation in pulmonary embolism (PE) remains unclear. This study aimed to evaluate the predictive value of a novel Inflammatory Burden Index (IBI) for long-term mortality in patients with acute PE. Methods A total of 1642 patients with acute PE were retrospectively analysed. The optimal cut-off for IBI was determined using maximally selected rank statistics. The association between high IBI and all-cause mortality was assessed using multivariable Cox proportional hazards models. The predictive performance of IBI and its individual components was compared using time-dependent receiver operating characteristic (ROC) curves. Variable importance for mortality prediction was further evaluated using random survival forest (RSF) analysis. Results During a median follow-up of 41.2 months, 262 patients (16.0%) died. High IBI was independently associated with increased risk of all-cause mortality (adjusted HR 2.33, 95% CI 1.78 to 3.04; p<0.001). Time-dependent ROC analysis demonstrated that IBI provided superior prognostic accuracy for mortality, with area under the curve (AUC) values of 0.73, 0.74 and 0.75 at 1, 3 and 5 years, respectively, which were higher than those of C-reactive protein, neutrophil count and lymphocyte count. Addition of IBI to the basic clinical model significantly improved the AUC at all time points. RSF analysis confirmed that IBI was the most important inflammatory predictor of long-term mortality. Conclusions The IBI is a robust and independent predictor of long-term mortality in patients with acute PE and offers incremental prognostic value beyond conventional risk factors. Incorporating IBI into clinical risk stratification may improve patient management and outcomes.
引用
- BMJ Open Respiratory Research:Innovative Inflammatory Burden Index for identification of high mortality risk in patients with pulmonary embolism: a large retrospective cohort study
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。